Cited by 6,066Global Cancer Incidence and ScreeningCancer survivorship and careEconomic and Financial Impacts of Cancer

Cancer treatment and survivorship statistics, 2016

Open access
Miller, Kimberly D., Siegel, Rebecca L., Lin, Chun Chieh, Mariotto, Angela B., Kramer, Joan L., Rowland, Julia H., Stein, Kevin D., Alteri, Rick +1 more·2016·CA: A Cancer Journal for Clinicians

Abstract

The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment‐related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost one‐half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care. CA Cancer J Clin 2016;66:271‐289. © 2016 American Cancer Society

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3322/caac.21349

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Breast cancer is the most prevalent cancer among women worldwide.

    “breast cancer is the most prevalent cancer among women worldwide (Miller et al., 2016).”

    From The effects of physical activity on cortisol and sleep: A systematic review and meta-analysis. (2022) · cites this paper as Miller et al., 2016

    The Selected Findings: Cancer Prevalence section ranks breast cancer first among cancers prevalent in women in the United States in 2016. It does not establish that breast cancer is the most prevalent cancer among women worldwide; the claim extends the paper’s US finding to a global population. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In the USA, there are more than 600,000 survivors of young adult cancer diagnosed at ages 18-39.

    “In the USA, there are more than 600,000 survivors of young adult (YA) cancer, aged 18–39 at diagnosis [1–3].”

    From Improving symptom management for survivors of young adult cancer: rationale and study protocol for a pilot randomized controlled trial (2024) · cites this paper as [3]

    The Cancers in Children and Adolescents section estimates 47,180 US survivors aged 15–19, while Selected Findings: Cancer Prevalence gives an all-ages total. Neither gives a count of people diagnosed at ages 18–39. Searches for “600,000” and “18-39” found no passage supporting the claimed figure. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 7

  1. Siegel RL, Miller KD, Jemal A. Cancer sta- tistics, 2016. CA Cancer J Clin. 2016;66:7- 30.
  2. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Stag- ing Manual. 7th ed. New York: Springer; 2010.
  3. Barr RD, Ferrari A, Ries L, Whelan J, Bleyer WA. Cancer in adolescents and young adults: a narrative review of the current status and a view of the future [published online ahead of print March 21, 2016]. JAMA Pediatr. doi: 10.1002/ jamapediatrics.2015.4689. · DOI
  4. Faderl S, Jeha S, Kantarjian HM. The biol- ogy and therapy of adult acute lympho- blastic leukemia. Cancer. 2003;98:1337- 1354.
  5. Pui CH, Robison LL, Look AT. Acute lym- phoblastic leukaemia. Lancet. 2008;371: 1030-1043.
  6. Sitas F, Weber MF, Egger S, Yap S, Chiew M, O'Connell D. Smoking cessa- tion after cancer. J Clin Oncol. 2014;32: 3593-3595.
  7. Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimu- mab or monotherapy in untreated mela- noma. N Engl J Med. 2015;373:23-34.

Cited by

Sorted by citations

Authors
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A.
Affiliations
  • American Cancer Society (US)
  • National Cancer Institute (US)
  • Emory University (US)
Corresponding author
Miller, Kimberly D.
Venue
CA: A Cancer Journal for Clinicians
Publisher
Wiley
Published
2016-06-02
Volume
66
Issue
4
Pages
271-289
ISSN
  • 0007-9235 (ISSN-L)
  • 1542-4863
OpenAlex
W2915478882
Cited by
6,066
References
131
Citations by year
2026: 28 · 2025: 112 · 2024: 234 · 2023: 325 · 2022: 369 · 2021: 717 · 2020: 958 · 2019: 1046 · 2018: 860 · 2017: 717 · 2016: 347 · 2015: 305 · 2014: 42 · 2013: 2
FWCI
533.98
Type
journal article
Language
en
Open access
Locations
  • CA A Cancer Journal for Clinicians (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords
cancer survivorship, cancer incidence trends, cancer treatment patterns, treatment side effects, prostate cancer, colon and rectum cancer, melanoma, breast cancer, endometrial cancer, SEER database
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, American Cancer Society, Breast Neoplasms, Child, Child, Preschool, Colonic Neoplasms, Female, Humans, Infant, Infant, Newborn, Male, Melanoma, Middle Aged, Neoplasms, Prostatic Neoplasms, Registries, Risk Factors, Skin Neoplasms, United States, Uterine Neoplasms, Incidence, Prevalence, Survival Rate, Survivors, Evidence-Based Medicine, National Cancer Institute (U.S.)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review